1. A6.07 Tissue- and cell-specific transcriptomes indicate systemic nature of ra and revealed combinations of protein biomarkers relevant for disease characterisation in serum. (24th February 2016) Authors: Smiljanovic, B; Stuhlmüller, B; Sörensen, T; Bonin, M; Pade, S; Backhaus, B; Maslinski, W; Burmester, GR; Radbruch, A; Grützkau, A; Häupl, T Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A6.37 The synovial tissue transcriptome reveals combinations of protein biomarkers for unambiguous identification of RA patients from synovial fluid and for quantification of disease activity in serum. (13th February 2015) Authors: Smiljanovic, B; Stuhlmüller, B; Bonin, M; Pade, S; Backhaus, B; Burmester, GR; Radbruch, A; Grützkau, A; Häupl, T Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A7.17 Microarray Gene Expression Profiling of Rheumatoid Arthritis Patients for Prediction of Response to Methotrexate Treatment. (25th February 2013) Authors: Mans, K; Tandon, N; Sohnrey, C; Bolle, S; Grützkau, A; Burmester, GR; Häupl, T; Stuhlmüller, B Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 1(2013) Page Start: A54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Does gene expression analysis inform us in rheumatoid arthritis?. (7th December 2009) Authors: Häupl, T; Stuhlmüller, B; Grützkau, A; Radbruch, A; Burmester, G-R Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 1 Page Start: i37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P134/O32 Selective expansion of a thymic-derived and functionally competent regulatory T cell population by low-dose IL-2 therapy in patients with refractory SLE. (March 2019) Authors: Humrich, JY; von Spee-Mayer, C; Siegert, E; Bertolo, M; Rose, A; Abdirama, D; Enghard, P; Stuhlmüller, B; Hiepe, F; Alexander, T; Feist, E; Radbruch, A; Burmester, G-R; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗